Semaglutide, which is also available under the brand names Ozempic and Rybelsus, is a GLP-1 receptor agonist that has been shown to help people with type 2 diabetes lose weight, lower glucose levels, and protect against diabetes-related heart complications
American Journal of Obstetrics and Gynecology, 143(5), 543-550
They will also monitor your progress and make any necessary adjustments to your treatment plan
The right choice depends on: Your goal : If maximum weight loss is the priority and you tolerate higher doses well, tirzepatide may have a slight edge based on trial data
P is a wellness tool, not a medical device
However, one of the most common mistakes is treating symptoms before identifying the underlying cause of the problem